435 related articles for article (PubMed ID: 36426370)
1.
Larid G; Delwail A; Dalle T; Vasseur P; Silvain C; Jégou JF; Morel F; Lecron JC; Gervais E
Front Immunol; 2022; 13():993363. PubMed ID: 36426370
[TBL] [Abstract][Full Text] [Related]
2. Cytokine profile characterization of naïve patients with psoriasis and psoriatic arthritis: implications for a pathogenic disease continuum.
Ruscitti P; Esposito M; Di Cola I; Pellegrini C; De Berardinis A; Mastrangelo M; Gianneramo C; Barile A; Fargnoli MC; Cipriani P
Front Immunol; 2023; 14():1229516. PubMed ID: 37520537
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo PBMC cytokine profile in familial Mediterranean fever patients: Involvement of IL-1β, IL-1α and Th17-associated cytokines and decrease of Th1 and Th2 cytokines.
Ibrahim JN; Jounblat R; Delwail A; Abou-Ghoch J; Salem N; Chouery E; Megarbane A; Medlej-Hashim M; Lecron JC
Cytokine; 2014 Oct; 69(2):248-54. PubMed ID: 25025954
[TBL] [Abstract][Full Text] [Related]
4. The cardiometabolic conditions of psoriatic disease.
Toussirot E; Gallais-Sérézal I; Aubin F
Front Immunol; 2022; 13():970371. PubMed ID: 36159785
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-17A Is Produced by CD4+ but Not CD8+ T Cells in Synovial Fluid Following T Cell Receptor Activation and Regulates Different Inflammatory Mediators Compared to Tumor Necrosis Factor in a Model of Psoriatic Arthritis Synovitis.
Xu X; Davelaar N; Mus AM; Asmawidjaja PS; Hazes JMW; Baeten DLP; Vis M; Bisoendial RJ; Prens EP; Lubberts E
Arthritis Rheumatol; 2020 Aug; 72(8):1303-1313. PubMed ID: 32243724
[TBL] [Abstract][Full Text] [Related]
6. Comparison and subsets analysis of peripheral CD4
Gao W; Lei Y; Guo X; Luo Y; Zhang Z; Xi Y; Wang W; Xia W; Wang Z; Niu X; Chen G; Yue T
Mol Immunol; 2023 Nov; 163():174-180. PubMed ID: 37812989
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of interferon gamma by mitogen-stimulated peripheral blood mononuclear cells among Kuwaiti psoriasis patients.
Mahmoud F; Abul H; al-Seleh Q; Morgan G; Haines D; al-Ramly M; Burleson J; Kreutzer D
J Dermatol; 1999 Jan; 26(1):23-8. PubMed ID: 10063208
[TBL] [Abstract][Full Text] [Related]
8. Functional significance of MAIT cells in psoriatic arthritis.
Raychaudhuri SK; Abria C; Mitra A; Raychaudhuri SP
Cytokine; 2020 Jan; 125():154855. PubMed ID: 31541902
[TBL] [Abstract][Full Text] [Related]
9. From PsO to PsA: the role of T
Lobão B; Lourenço D; Giga A; Mendes-Bastos P
Front Med (Lausanne); 2024; 11():1346757. PubMed ID: 38405187
[TBL] [Abstract][Full Text] [Related]
10. The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies.
Novelli L; Chimenti MS; Chiricozzi A; Perricone R
Autoimmun Rev; 2014 Jan; 13(1):64-9. PubMed ID: 24021172
[TBL] [Abstract][Full Text] [Related]
11. Cytokine Signatures in Psoriatic Arthritis Patients Indicate Different Phenotypic Traits Comparing Responders and Non-Responders of IL-17A and TNFα Inhibitors.
Skougaard M; Ditlev SB; Søndergaard MF; Kristensen LE
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047315
[TBL] [Abstract][Full Text] [Related]
12. Early diagnosis of psoriatic arthritis among psoriasis patients: clinical experience sharing.
Su YJ
Clin Rheumatol; 2020 Dec; 39(12):3677-3684. PubMed ID: 32468320
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of interleukin-2 by anti-CD3-stimulated peripheral blood mononuclear cells in patients with psoriatic arthritis and patients with cutaneous psoriasis.
Bos F; Capsoni F; Molteni S; Raeli L; Diani M; Altomare A; Garavaglia M; Garutti C; Frigerio E; Banfi G; Altomare G; Reali E
Clin Exp Dermatol; 2014 Apr; 39(3):385-90. PubMed ID: 24772485
[TBL] [Abstract][Full Text] [Related]
14. Blood-Based Immune Profiling Combined with Machine Learning Discriminates Psoriatic Arthritis from Psoriasis Patients.
Mulder MLM; He X; van den Reek JMPA; Urbano PCM; Kaffa C; Wang X; van Cranenbroek B; van Rijssen E; van den Hoogen FHJ; Joosten I; Alkema W; de Jong EMGJ; Smeets RL; Wenink MH; Koenen HJPM
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681660
[TBL] [Abstract][Full Text] [Related]
15. Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study.
Schett G; Chen W; Gao S; Chakravarty SD; Shawi M; Lavie F; Zimmermann M; Sharaf M; Coates LC; Siebert S
Arthritis Res Ther; 2023 Aug; 25(1):150. PubMed ID: 37587493
[TBL] [Abstract][Full Text] [Related]
16. Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database.
Pina Vegas L; Penso L; Claudepierre P; Sbidian E
JAMA Dermatol; 2022 May; 158(5):513-522. PubMed ID: 35319735
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies.
Sánchez-Rodríguez G; Puig L
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373452
[TBL] [Abstract][Full Text] [Related]
18. Treatment Patterns and Healthcare Resource Utilization Among Newly Diagnosed Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis, and Hidradenitis Suppurativa Patients with Past Diagnosis of an Inflammatory Condition: A Retrospective Cohort Analysis of Claims Data in the United States.
Hopson S; Gibbs LR; Syed S; Low R; McClung L; Beaty S
Adv Ther; 2023 Oct; 40(10):4358-4376. PubMed ID: 37486558
[TBL] [Abstract][Full Text] [Related]
19. Cytokine Signature in Schnitzler Syndrome: Proinflammatory Cytokine Production Associated to Th Suppression.
Masson Regnault M; Frouin E; Jéru I; Delwail A; Charreau S; Barbarot S; Néel A; Masseau A; Puéchal X; Kyndt X; Gayet S; Lifermann F; Asli B; Balguerie X; Blanchard-Delaunay C; Aubin F; Rizzi R; Rongioletti F; Boyé T; Gusdorf L; Bessis D; Morel F; Hainaut E; Lipsker D; Lecron JC
Front Immunol; 2020; 11():588322. PubMed ID: 33324407
[TBL] [Abstract][Full Text] [Related]
20. Suppression of IL-12/IL-23 p40 subunit in the skin and blood of psoriasis patients by Tofacitinib is dependent on active interferon-γ signaling in dendritic cells: Implications for the treatment of psoriasis and interferon-driven diseases.
Vincken NLA; Welsing PMJ; Silva-Cardoso SC; Bekker CPJ; Lopes AP; Olde Nordkamp M; Leijten EFA; Radstake TRDJ; Angiolilli C
Exp Dermatol; 2022 Jun; 31(6):962-969. PubMed ID: 35297512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
